|
MYBL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01429999954661E-08 |
| Normal-vs-Stage2 |
9.017500E-04 |
| Normal-vs-Stage3 |
2.07330000001615E-06 |
| Normal-vs-Stage4 |
3.162500E-03 |
| Stage1-vs-Stage2 |
9.512600E-01 |
| Stage1-vs-Stage3 |
2.563800E-01 |
| Stage1-vs-Stage4 |
4.217800E-01 |
| Stage2-vs-Stage3 |
4.413800E-01 |
| Stage2-vs-Stage4 |
2.699800E-01 |
| Stage3-vs-Stage4 |
1.001360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.2854608750531E-14 |
| Normal-vs-AfricanAmerican |
9.72700000000382E-05 |
| Normal-vs-Asian |
1.817360E-01 |
| Caucasian-vs-AfricanAmerican |
5.457200E-01 |
| Caucasian-vs-Asian |
4.557200E-01 |
| AfricanAmerican-vs-Asian |
3.566000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.64957999999604E-05 |
| Male-vs-Female |
7.894100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.25490000000428E-05 |
| Normal-vs-Extreme_Weight |
1.5975000000612E-07 |
| Normal-vs-Obese |
1.88982999999032E-05 |
| Normal-vs-Extreme_Obese |
9.436300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.205000E-01 |
| Normal_Weight-vs-Obese |
2.580200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.536400E-01 |
| Extreme_Weight-vs-Obese |
5.533800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.531000E-01 |
| Obese-vs-Extreme_Obese |
8.303800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.000600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.67029748207892E-11 |
| Normal-vs-Age(61-80Yrs) |
2.70279999492473E-08 |
| Normal-vs-Age(81-100Yrs) |
5.414500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.561700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.622300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.282830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.261400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.956200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.88875648033627E-13 |
| Normal-VS-Type2 PRCC |
1.242900E-04 |
| Normal-VS-KIRP CIMP |
2.921300E-03 |
| Normal-VS-Unclassified PRCC |
9.957100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.350450E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.539700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.979380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.358370E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.780300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.577600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.557800E-03 |
| Normal-vs-N1 |
3.839900E-04 |
| Normal-vs-N2 |
2.574600E-01 |
| N0-vs-N1 |
5.201800E-01 |
| N0-vs-N2 |
9.293400E-01 |
| N1-vs-N2 |
8.250000E-01 |
|
|
